In 2019, ESC/EAS guidelines recommend Lp(a) measurement at least once in a lifetime in subjects at very high and high CV risk and in those with a family history of premature cardiovascular disease, to reclassify patients with borderline risks [6]. Here, LPA is linked to cardiovascular disorder.